Gyre Therapeutics
GYRE
#5622
Rank
A$1.51 B
Marketcap
$16.22
Share price
19.95%
Change (1 day)
-41.91%
Change (1 year)

EPS for Gyre Therapeutics (GYRE)

EPS in 2024 (TTM): $0.16

According to Gyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.22. In 2023 the company made an earnings per share (EPS) of -$2.22 a decrease over its 2022 EPS that were of $0.006875.

EPS history for Gyre Therapeutics from 2021 to 2024

Annual EPS

Year EPS Change
2024 (TTM)$0.16-107.25%
2023-$2.22-32451.8%
2022$0.006875-90.93%
2021$0.07576